Medications

Gefapixant leads to modest improvements in cough

For adults with refractory or unexplained chronic cough, gefapixant leads to modest improvement in cough frequency, severity, and quality of life, according to a review published online Sept. 11 in the Journal of the American ...

Vaccination

Pharma firm, labs share tech for COVID research equity: WHO

A global COVID-19 knowledge-sharing platform has secured three new licensing agreements to transfer vaccine technologies, including one with the first private manufacturer to join the initiative, the World Health Organization ...

page 18 from 40